Sculptor Capital’s SkinHealth Systems SKIN Stock Holding History

Sculptor Capital’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,355	Closed	-$2.26M	–	1188
2021 Q3	$2.26M	Buy	+4,355	New	+$1.92M	0.02%	457
2021 Q1	–	Sell	-11,223	Closed	-$2.54M	–	781
2020 Q4	$2.54M	Buy	+11,223	New	+$2.42M	0.01%	277

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Sculptor Capital's SKIN Position: Q4 2021 in Review

Sculptor Capital sold out of SkinHealth Systems (SKIN) in Q4 2021, closing a stake of 4,355 shares — an estimated $2.26M sold.

Sculptor Capital first reported a position in SKIN in Q4 2020 and held it in 2 quarters. The position peaked at $2.54M in Q4 2020. 165 funds tracked by Wall St. Rank hold SKIN as of Q4 2021.

Sculptor Capital reported no remaining SkinHealth Systems position as of Q4 2021 after selling out during the quarter.
Sculptor Capital sold 4,355 SkinHealth Systems shares in Q4 2021, an estimated $2.26M.
Sculptor Capital first reported a position in SkinHealth Systems in Q4 2020 and held it in 2 quarters.
Sculptor Capital's SkinHealth Systems position peaked at $2.54M in Q4 2020.
165 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2021.

Based on Sculptor Capital's 13F filing for Q4 2021, filed 11 Feb 2022.